myTomorrows’ COO Vanessa Lemarié Named in Sifted’s Top 100 Women in Tech Europe

Michel van Harten 10 Oct 2025

2 mins read

share this post

Vanessa Lemarie

We are proud to share that our Chief Operating Officer, Vanessa Lemarié, has been named in Sifted’s Top 100 Women in Tech in Europe 2025 list, a recognition that celebrates the most impactful and inspiring women shaping the European technology ecosystem. 

The annual list, curated by Sifted (backed by the Financial Times) in partnership with Sistafund and Station F, shines a spotlight on founders, investors, operators, and ecosystem builders whose work is driving real change. Nominees are selected based on the scale of their impact, the innovation and significance of their work, their leadership within the community, and their potential to inspire the next generation of leaders in technology. 

As Chief Operating Officer at myTomorrows, Vanessa is responsible for business operations in clinical trial patient recruitment, expanded access programs and real-world data. Her work is central to the company’s mission of broadening global access to pre-approval treatments via clinical trials and expanded access programs.  

Vanessa champions strategic efficiency gains ensuring quality and compliance is central to the every-day running of the business, whilst reinforcing patient-centricity as a core value. Under her leadership, the myTomorrows Operations teams have launched multiple new programs this year, expanding patient access to treatments, while also reaching a record number of patients supported. 

“Working in Healthtech truly means working at an intersection of care and technological advancement. At myTomorrows I’m particularly proud of our team who expertly support patients at every step of their journey with safety, compliance and efficiency top of mind.” 

Vanessa Lemarié

Vanessa’s passion for using innovative technology to solve healthcare challenges is also reflected in her previous role as COO at Ada Health, the world’s most popular symptom assessment and care navigation platform. There, she expanded the platform’s global reach and made it more accessible to diverse populations.  

Before Ada Health, Vanessa spent 15 years in leadership roles at Bayer Pharmaceuticals, working across most of the company’s franchises. She was the first to launch the company’s partnerships with telemedicine providers in several countries, enabling women to have easier access to trustworthy conversations with qualified healthcare professionals, leveraging nascent technological innovation.  

We’re incredibly proud to have Vanessa as part of our mighty team and congratulate her on this prestigious recognition of her achievements.  

share this post

TechAwardInnovation

Michel van Harten 10 Oct 2025

more articles

view all blogs
myTomorrows CUN partnership logo lock up
Clinical Trial Recruitment
Partnership
AI

myTomorrows and Clínica Universidad de Navarra Partner to Advance AI-Powered Clinical Trial Infrastructure in Spain

myTomorrows Team

26 Mar 2026

5 mins read

Theo Cantero, Patient Navigator at myTomorrows
Clinical Trials
Brain Tumours
Patient Navigation

Supporting People with Brain Tumours: An Interview with Theo Cantero, Patient Navigator at myTomorrows

Andrea Enguita

25 Mar 2026

8 mins read

Michel van Harten AWS Pioneers
AI

myTomorrows Joins AWS Pioneers Project 2026

myTomorrows Team

18 Mar 2026

7 mins read

myTomorrows Trust Center blog

myTomorrows Trust Center: Security, Compliance, and Transparency

Filippo Mandrini

19 Feb 2026

9 mins read

Man with ALS performing physical therapy
ALS
Neurological disorders
Physical Therapy

The Role of Physical Therapy in ALS Care

Andrea Enguita

14 Jan 2026

16 mins read

Medical researchers
Rare Disease
MAP

Sentynl Selects myTomorrows to Lead Managed Access Program

myTomorrows Team

15 Dec 2025

4 mins read

Trial sites
Clinical Trials
HCPs
Oncology

Whitepaper: Advancing Neuro-Oncology Clinical Trial Access

Daniël Groeneweg

27 Nov 2025

8 mins read

Person with end-stage Parkinson's and caregiver
Neurological disorders
Parkinson's disease
End-stage Parkinson's

End-Stage Parkinson’s Disease: Symptoms, Care, and Support

Andrea Enguita

18 Nov 2025

21 mins read

Referrals
Clinical researchers
Trial sites
Clinical Trials

Getting Started: myTomorrows Referral Platform for Site Staff

Adrianne Rivard

14 Nov 2025

10 mins read

myTomorrows Avego finding announcement
Investment
Funding
Patient Access

Our next chapter: €25M growth investment to scale patient access worldwide

Michel van Harten

11 Nov 2025

7 mins read